Q-linea AB (OSTO:QLINEA) Short Interest


OSTO:QLINEA Q-linea AB OSTO:QLINEA
67 GF Score
Price kr17.60
GF Value kr19.86
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Q-linea AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

OSTO:QLINEA vs ABT, SYK, MDT: Short Interest Comparison

For the Medical Devices subindustry, Q-linea AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Q-linea AB Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Q-linea AB's Short Interest distribution charts can be found below:

* The bar in red indicates where Q-linea AB's Short Interest falls into.


OSTO:QLINEA
67GF Score
Q-linea AB OSTO:QLINEA
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Q-linea AB (OSTO:QLINEA) Overvalued in 2026?

Based on GuruFocus' analysis, Q-linea AB stock appears to be undervalued. The current stock price of kr17.60 is trading 11.4% below its estimated GF Value™ of kr19.86. GuruFocus considers Q-linea AB to be Modestly Undervalued.

Key valuation signals for OSTO:QLINEA:

  • Short Interest:
  • GF Value™: kr19.86 vs. price of kr17.60 (11.4% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the OSTO:QLINEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Q-linea AB Business Description

Other Exchanges 3F80:Germany
Address Dag Hammarskjolds vag 52 A, Uppsala, SWE, SE-752 37
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
67GF Score

Get the complete analysis for OSTO:QLINEA

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr17.60
Price
kr19.86
GF Value